UVA is working with VDH to trace contacts and assist those exposed, aiming to limit the spread of this potentially ...

Bonner said anyone exhibiting symptoms of the disease should make an appointment with Student Health and Wellness for ...

For patients transitioning from rituximab to ravulizumab, meningococcal vaccination can be safely done within 6 months after stopping rituximab.

According to the Virginia Department of Health, Virginia is not experiencing an outbreak of meningococcal disease, a serious ...

Tips to identify measles as several states report outbreaks of three cases or more. Texas has already reported more than 145 ...

The U.S. is dealing with a measles outbreak, including one in New Jersey and new cases in New York City. See what the measles look like here.

Measles symptoms resemble other common childhood illnesses, but occur all together. Early symptoms include a relentless cough ...

Penmenvy protects against meningococcal serotypes A, B, C, W and Y. CDC vaccine advisors are set to discuss recommendations for the vaccine on Feb. 26. The FDA approved GSK’s pentavalent ...

Nova Scotia Health says a case of invasive meningococcal disease was reported in a student at Cole Harbour High School last week. Close contacts and people who may have been directly exposed have ...

Feb. 18, 2025 – The FDA has approved a new 5-in-1 shot to protect against meningococcal infections or invasive meningococcal disease (IMD) in people ages 10 to 25 years. Sold as Penmenvy ...

(RTTNews) - GSK plc (GSK, GSK.L) announced that the US Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 ...